BOWIE, Md., June 03, 2025 (GLOBE NEWSWIRE) -- The Epilepsy Foundation of America announced today that it has awarded $250,000 ...

ANN ARBOR, Mich., June 03, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs ...

SHENZHEN, China, June 03, 2025 (GLOBE NEWSWIRE) -- XPOLAR, an innovator in sports recovery and wellness technology, ...

TORONTO, June 02, 2025 (GLOBE NEWSWIRE) -- EmergConnect’s digital platform helps hospitals cut ER triage time by up to 60%.

The Trader’s Mind bridges the gap between strategy and success, offering tools like trading journals, breathing techniques, ...

Vital Wound Care also collaborates with a wide network of providers, including Home Health agencies, skilled nursing facilities (SNFs), transitional hospitals, and independent physicians, to offer ...

Result of the payment of dividends in shares and record of the corresponding capital increase ...

Mongolian Gerbil Research Unlocks Critical Insights for Ischemic Stroke and Neurodegenerative Disease Treatments. BOSTON, MASSACHUSETTS, June 03, 2025 (GLOBE NEWSWIRE) -- BIOXYTRA ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, today announced it entered an exclusive, worldwide ...

This patent strengthens Renovaro’s AI and machine learning intellectual property portfolio by protecting novel methods for integrating and harmonizing diverse biomedical data sources—such as genomics, ...

To request a meeting and to register for the conference, click here: Dogwood Therapeutics (Nasdaq: DWTX) is a development-stage biopharmaceutical company focused on developing new medicines to treat ...

NCT05539430 is a Phase 1, open label, dose escalation, multicenter study to evaluate Claudin 18.2-targeting CAR-T cells (LB1908) in adult patients with unresectable, locally advanced or metastatic ...